Hypercholesterolemic mice exhibit lymphatic vessel dysfunction and degeneration

American Journal of Pathology

Volumn 175, Issue 3, 2009, Pages 1328-1337

  Hwee, Ying Lim ^a   Rutkowski, Joseph M ^b   Helft, Julie ^c   Reddy, Sai T ^b   Swartz, Melody A ^b   Randolph, Gwendalyn J ^c   Angeli, Véronique ^a,c,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b EPFL   (Switzerland)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DEGENERATION; DENDRITIC CELL; FLUID TRANSPORT; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA TYPE 3; IMMUNE DEFICIENCY; LYMPH VESSEL; LYMPHATIC DRAINAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULARIZATION;

EID: 70349249424     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080963     Document Type: Article

References (49)

1. Nanjee MN, Cooke CJ, Wong JS, Hamilton RL, Olszewski WL, Miller NE: Composition and ultrastructure of size subclasses of normal human peripheral lymph lipoproteins: quantification of cholesterol uptake by HDL in tissue fluids. J Lipid Res 2001, 42:639-648
2. Swartz MA: The physiology of the lymphatic system. Adv Drug Deliv Rev 2001, 50:3-20
3. Schirger A, Harrison E, Janes J: Idiopathic lymphedema. Review of 131 cases. JAMA 1962, 182:14-22
4. Rutkowski JM, Moya M, Johannes J, Goldman J, Swartz MA: Secondary lymphedema in the mouse tail: lymphatic hyperplasia. VEGF-C upregulation, and the protective role of MMP-9. Microvasc Res 2006, 72:161-171
5. Ruocco V, Schwartz RA, Ruocco E: Lymphedema: an immunologically vulnerable site for development of neoplasms. J Am Acad Dermatol 2002, 47:124-127
6. Harwood CA, Mortimer PS: Causes and clinical manifestations of lymphatic failure. Clin Dermatol 1995, 13:459-471
7. Harvey NL, Srinivasan RS, Dillard ME, Johnson NC, Witte MH, Boyd K, Sleeman MW, Oliver G: Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity. Nat Genet 2005, 37:1072-1081 (Pubitemid 41486659)
8. Amann-Vesti BR, Franzeck UK, Bollinger A: Microlymphatic aneurysms in patients with lipedema. Lymphology 2001, 34:170-175
9. Bilancini S, Lucchi M, Tucci S, Eleuteri P: Functional lymphatic alterations in patients suffering from lipedema. Angiology 1995, 46:333-339
10. Burger D, Dayer JM: High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation? Autoimmun Rev 2002, 1:111-117
11. Sako A, Kitayama J, Kaisaki S, Nagawa H: Hyperlipidemia is a risk factor for lymphatic metastasis in superficial esophageal carcinoma. Cancer Lett 2004, 208:43-49 (Pubitemid 38501782)
12. van Ree JH, Gijbels MJ, van den Broek WJ, Hofker MH, Havekes LM: Atypical xanthomatosis in apolipoprotein E-deficient mice after cholesterol feeding. Atherosclerosis 1995, 112:237-243
13. -/- mice: link between cholesterol homeostasis and self-tolerance? J Lipid Res 2007, 48:52-65
14. Feingold KR, Elias PM, Mao-Qiang M, Fartasch M, Zhang SH, Maeda N: Apolipoprotein E deficiency leads to cutaneous foam cell formation in mice. J Invest Dermatol 1995, 104:246-250
15. Angeli V, Llodra J, Rong JX, Satoh K, Ishii S, Shimizu T, Fisher EA, Randolph GJ: Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity 2004, 21:561-574 (Pubitemid 39370511)
16. Yamamoto A, Kamiya T, Yamamura T, Yokoyama S, Horiguchi Y, Funahashi T, Kawaguchi A, Miyake Y, Beppu S, Ishikawa K, Matsuzawa Y, Takaichi S: Clinical features of familial hypercholesterolemia. Arteriosclerosis 1989, 9:I66-74
17. Shimokawa H: Primary endothelial dysfunction: atherosclerosis. J Mol Cell Cardiol 1999, 31:23-37
18. Angeli V, Ginhoux F, Llodra J, Quemeneur L, Frenette PS, Skobe M, Jessberger R, Merad M, Randolph GJ: B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 2006, 24:203-215 (Pubitemid 43214589)
19. Dellinger MT, Hunter RJ, Bernas MJ, Witte MH, Erickson RP: Chy-3 mice are Vegfc haploinsufficient and exhibit defective dermal superficial to deep lymphatic transition and dermal lymphatic hypoplasia. Dev Dyn 2007, 236:2346-2355
20. Kajiya K, Hirakawa S, Detmar M: Vascular endothelial growth factor-A mediates ultraviolet B-induced impairment of lymphatic vessel function. Am J Pathol 2006, 169:1496-1503 (Pubitemid 351194380)
21. Swartz MA, Berk DA, Jain RK: Transport in lymphatic capillaries. I. Macroscopic measurements using residence time distribution theory. Am J Physiol 1996, 270:H324-H329
22. Swartz MA, Kaipainen A, Netti PA, Brekken C, Boucher Y, Grodzinsky AJ, Jain RK: Mechanics of interstitial-lymphatic fluid transport: theoretical foundation and experimental validation. J Biomech 1999, 32:1297-1307 (Pubitemid 29490874)
23. Robbiani DF, Finch RA, Jager D, Muller WA, Sartorelli AC, Randolph GJ: The leukotriene C4 transporter MRP1 regulates CCL19 (MIP-3β, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 2000, 103:757-768
24. Breslow JL: Mouse models of atherosclerosis. Science 1996, 272:685-688
25. Reddick RL, Zhang SH, Maeda N: Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler Thromb 1994, 14:141-147
26. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R: ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994, 14:133-140 (Pubitemid 24028177)
27. Lin RY, Choudhury RP, Cai W, Lu M, Fallon JT, Fisher EA, Vlassara H: Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 2003, 168:213-220 (Pubitemid 36703319)
28. Nakagami H, Osako MK, Takami Y, Hanayama R, Koriyama H, Mori M, Hayashi H, Shimizu H, Morishita R: Vascular protective effects of ezetimibe in ApoE-deficient mice. Atherosclerosis 2009, 203:51-58
29. Randolph GJ, Angeli V, Swartz MA: Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol 2005, 5:617-628 (Pubitemid 41113193)
30. Kajiya K, Sawane M, Huggenberger R, Detmar M: Activation of the VEGFR-3 pathway by VEGF-C attenuates UVB-induced edema formation and skin inflammation by promoting lymphangiogenesis. J Invest Dermatol 2009, 129:1292-1298
31. Schmid-Schonbein GW: Microlymphatics and lymph flow. Physiol Rev 1990, 70:987-1028
32. Cooke CJ, Nanjee MN, Stepanova IP, Olszewski WL, Miller NE: Variations in lipid and apolipoprotein concentrations in human leg lymph: effects of posture and physical exercise. Atherosclerosis 2004, 173:39-45
33. Ludewig B, Jaggi M, Dumrese T, Brduscha-Riem K, Odermatt B, Hengartner H, Zinkernagel RM: Hypercholesterolemia exacerbates virus-induced immunopathologic liver disease via suppression of antiviral cytotoxic T cell responses. J Immunol 2001, 166:3369-3376 (Pubitemid 33117338)
34. de Bont N, Netea MG, Demacker PN, Verschueren I, Kullberg BJ, van Dijk KW, van der Meer JW, Stalenhoef AF: Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J Lipid Res 1999, 40:680-685 (Pubitemid 29173771)
35. Netea MG, Demacker PN, de Bont N, Boerman OC, Stalenhoef AF, van der Meer JW, Kullberg BJ: Hyperlipoproteinemia enhances susceptibility to acute disseminated Candida albicans infection in low-density-lipoprotein-receptor- deficient mice. Infect Immun 1997, 65:2663-2667
36. Laskowitz DT, Lee DM, Schmechel D, Staats HF: Altered immune responses in apolipoprotein E-deficient mice. J Lipid Res 2000, 41:613-620 (Pubitemid 30220665)
37. Baluk P, Fuxe J, Hashizume H, Romano T, Lashnits E, Butz S, Vestweber D, Corada M, Molendini C, Dejana E, McDonald DM: Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med 2007, 204:2349-2362 (Pubitemid 47529321)
38. DeMaio L, Rouhanizadeh M, Reddy S, Sevanian A, Hwang J, Hsiai TK: Oxidized phospholipids mediate occludin expression and phosphorylation in vascular endothelial cells. Am J Physiol Heart Circ Physiol 2006, 290:H674-H683
39. Muthuchamy M, Zawieja D: Molecular regulation of lymphatic contractility. Ann NY Acad Sci 2008, 1131:89-99
40. Paulus WJ, Frantz S, Kelly RA: Nitric oxide and cardiac contractility in human heart failure: time for reappraisal. Circulation 2001, 104:2260-2262 (Pubitemid 33049503)
41. Johnson LA, Clasper S, Holt AP, Lalor PF, Baban D, Jackson DG: An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J Exp Med 2006, 203:2763-2777 (Pubitemid 44833351)
42. Liao S, Ruddle NH: Synchrony of high endothelial venules and lymphatic vessels revealed by immunization. J Immunol 2006, 177:3369-3379 (Pubitemid 44277857)
43. Halin C, Tobler NE, Vigl B, Brown LF, Detmar M: VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes. Blood 2007, 110:3158-3167 (Pubitemid 350106307)
44. Petrova TV, Karpanen T, Norrmen C, Mellor R, Tamakoshi T, Finegold D, Ferrell R, Kerjaschki D, Mortimer P, Yla-Herttuala S, Miura N, Alitalo K: Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med 2004, 10:974-981 (Pubitemid 39273739)
45. Makinen T, Adams RH, Bailey J, Lu Q, Ziemiecki A, Alitalo K, Klein R, Wilkinson GA: PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev 2005, 19:397-410 (Pubitemid 40189302)
46. Gale NW, Thurston G, Hackett SF, Renard R, Wang Q, McClain J, Martin C, Witte C, Witte MH, Jackson D, Suri C, Campochiaro PA, Wiegand SJ, Yancopoulos GD: Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell 2002, 3:411-423
47. Tammela T, Saaristo A, Holopainen T, Lyytikka J, Kotronen A, Pitkonen M, Abo-Ramadan U, Yla-Herttuala S, Petrova TV, Alitalo K: Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation. Nat Med 2007, 13:1458-1466 (Pubitemid 350224251)
48. Burman A, Haworth O, Hardie DL, Amft EN, Siewert C, Jackson DG, Salmon M, Buckley CD: A chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis. J Immunol 2005, 174:1693-1700
49. Cliff S, Bedlow AJ, Stanton AW, Mortimer PS: An in vivo study of the microlymphatics in psoriasis using fluorescence microlymphography. Br J Dermatol 1999, 140:61-66 (Pubitemid 29074532)